According to the Inuyama Symposium criteria, patients with hepatitis were diagnosed as having fulminant hepatitis when they developed grade II or more severe hepatic encephalopathy due to severe liver damage, as represented by prothrombin time values of ≤40 % of the standardized value, within 8 weeks of the onset of the hepatitis symptoms. The gene discussed is F2; the disease is Fulminant hepatitis.